FDA Drug Application (021746) for SURFAXIN by WINDTREE THERAP

Back to FDA Applications sponsored by WINDTREE THERAP

Application Number021746
Product Number001
FormSUSPENSION;INTRATRACHEAL
Dosage8.5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSURFAXIN
Active IngredientLUCINACTANT



Back to FDA Applications sponsored by WINDTREE THERAP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.